Payment overview · 2025
General Payments
$77.80
4 reported records · 3 companies
Healthcare provider profile · identity verified
Xinke Chen, MD
Allopathic & Osteopathic Physicians|Hospitalist · CORONA, CA · NPI 1780634857
Verified facts
What the public records show
CMS Open Payments records show Xinke Chen, MD received $77.80 in general payments during 2025 across 4 reported records.
MIMEDX Group, Inc. accounted for 51.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| MIMEDX Group, Inc. | Unresolved — no canonical attribution shown | $40.04 | 51.5% | 2 | 2025 |
| Edwards Lifesciences Corporation | Unresolved — no canonical attribution shown | $22.84 | 29.4% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $14.92 | 19.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $77.80 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) Normalized: edwards sapien 3 transcatheter heart valve thv |
Device | Edwards Lifesciences Corporation | $22.84 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $14.92 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 422 | 83 |
| Amlodipine Besylate | Amlodipine Besylate | 279 | 64 |
| Lisinopril | Lisinopril | 238 | 46 |
| Furosemide | Furosemide | 215 | 37 |
| Eliquis | Apixaban | 205 | 25 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 188 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 164 | 36 |
| Famotidine | Famotidine | 160 | 31 |
| Metformin Hcl | Metformin Hcl | 156 | 34 |
| Pantoprazole Sodium | Pantoprazole Sodium | 147 | 35 |
| Alprazolam | Alprazolam | 139 | 20 |
| Gabapentin | Gabapentin | 138 | 29 |
| Levothyroxine Sodium | Levothyroxine Sodium | 133 | 21 |
| Montelukast Sodium | Montelukast Sodium | 128 | 20 |
| Levetiracetam | Levetiracetam | 118 | 13 |
| Tamsulosin Hcl | Tamsulosin Hcl | 108 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 107 | 20 |
| Tramadol Hcl | Tramadol Hcl | 95 | 14 |
| Sodium Chloride | 0.9 % Sodium Chloride | 89 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 75 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 74 | 11 |
| Potassium Chloride | Potassium Chloride | 74 | 15 |
| Enoxaparin Sodium | Enoxaparin Sodium | 66 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 66 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 65 | 12 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 64 | suppressed |
| Lorazepam | Lorazepam | 63 | 14 |
| Omeprazole | Omeprazole | 63 | 14 |
| Enulose | Lactulose | 62 | suppressed |
| Losartan Potassium | Losartan Potassium | 62 | 18 |
| Glipizide | Glipizide | 61 | suppressed |
| Carvedilol | Carvedilol | 60 | 13 |
| Donepezil Hcl | Donepezil Hcl | 60 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 60 | suppressed |
| Novolin R | Insulin Regular, Human | 58 | 11 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 57 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 57 | suppressed |
| Simvastatin | Simvastatin | 56 | 17 |
| Finasteride | Finasteride | 55 | suppressed |
| Ibuprofen | Ibuprofen | 55 | 16 |
| Budesonide | Budesonide | 51 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 50 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 49 | 13 |
| Lactulose | Lactulose | 48 | 11 |
| Baclofen | Baclofen | 47 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 47 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 46 | suppressed |
| Azithromycin | Azithromycin | 46 | 36 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 46 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 45 | suppressed |
| Meropenem | Meropenem | 44 | suppressed |
| Metoprolol Succinate | Metoprolol Succinate | 44 | 15 |
| Risperidone | Risperidone | 42 | suppressed |
| Scopolamine | Scopolamine | 41 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 40 | 16 |
| Glycopyrrolate | Glycopyrrolate | 40 | suppressed |
| Olanzapine | Olanzapine | 40 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 39 | 31 |
| Alendronate Sodium | Alendronate Sodium | 38 | suppressed |
| Phenytoin | Phenytoin | 37 | suppressed |
| Allopurinol | Allopurinol | 35 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 32 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 31 | suppressed |
| Humulin R | Insulin Regular, Human | 30 | suppressed |
| Nifedipine Er | Nifedipine | 30 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | suppressed |
| Memantine Hcl | Memantine Hcl | 28 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 28 | suppressed |
| Atenolol | Atenolol | 27 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 27 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 27 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 27 | suppressed |
| Topiramate | Topiramate | 27 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 26 | suppressed |
| Januvia | Sitagliptin Phosphate | 26 | suppressed |
| Ozempic | Semaglutide | 26 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 25 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 25 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 25 | suppressed |
| Clonazepam | Clonazepam | 24 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 24 | 12 |
| Spironolactone | Spironolactone | 24 | suppressed |
| Ezetimibe | Ezetimibe | 23 | suppressed |
| Meloxicam | Meloxicam | 23 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 22 | suppressed |
| Latanoprost | Latanoprost | 22 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Valproic Acid | Valproic Acid | 22 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 21 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 21 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Fenofibrate | Fenofibrate | 20 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 20 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 20 | suppressed |
| Procrit | Epoetin Alfa | 19 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 19 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 18 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 18 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 17 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 16 | 11 |
| Insulin Aspart Flexpen | Insulin Aspart | 16 | suppressed |
| Linzess | Linaclotide | 16 | suppressed |
| Nystatin | Nystatin | 16 | suppressed |
| Ondansetron Odt | Ondansetron | 16 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 15 | suppressed |
| Cephalexin | Cephalexin | 15 | 14 |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 15 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 15 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | 11 |
| Brilinta | Ticagrelor | 14 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 14 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 13 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 13 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Methadone Hcl | Methadone Hcl | 13 | suppressed |
| Methylprednisolone | Methylprednisolone | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Tolvaptan | Tolvaptan | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 12 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Erythromycin | Erythromycin Base | 11 | suppressed |
| Levalbuterol Hcl | Levalbuterol Hcl | 11 | suppressed |
| Loperamide | Loperamide Hcl | 11 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 11 | suppressed |
| Oxycontin | Oxycodone Hcl | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Pregabalin | Pregabalin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $77.80 · 4 records | MIMEDX Group, Inc. | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), REPATHA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error